Accelerate Diagnostics, Inc.: Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services ...
manilatimes22h
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, ...
Aura Minerals Inc: Aura Announces Q4 2024 Production Results, Achieving 2024 Guidance
Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) ("Aura" or the "Company") announces Q4 2024 preliminary production results ...
manilatimes20h
Correcting & Replacing - Y-mAbs Provides Strategic Business Update and 2025 Priorities
Correcting & Replacing: Y-mAbs Therapeutics, Inc. is re-issuing in entirety its press release, originally issued on January 10, 2025 at 7:05 a.m. ET, to correct a scrivener's error in the presentation ...
Taiwan News23h
Y-mAbs Provides Strategic Business Update and 2025 Priorities
Novel Self-Assembly DisAssembly Pre-targeted Radioimmunotherapy (“SADA PRIT”) platform designed to improve upon traditional radioimmunotherapy by delivering high therapeutic dose while minimizing ...